Nisa Investment Advisors
PLRX icon

Nisa Investment Advisors’s Pliant Therapeutics PLRX Stock Holding History

Nisa Investment Advisors’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-916
Closed -$1.06K – 3063
2025
Q2 		$1.06K Sell
916
-252
-22% -$356 ﹤0.01% 2725
2025
Q1 		$1.58K Sell
1,168
-173
-13% -$1.05K ﹤0.01% 2531
2024
Q4 		$17.7K Buy
1,341
+294
+28% +$4.01K ﹤0.01% 1972
2024
Q3 		$11.7K Buy
1,047
+1,018
+3,510% +$12.7K ﹤0.01% 2067
2024
Q2 		$312 Sell
29
-66
-69% -$851 ﹤0.01% 2765
2024
Q1 		$1.42K Buy
95
+75
+375% +$1.24K ﹤0.01% 2298
2023
Q4 		$362 Sell
20
-30
-60% -$456 ﹤0.01% 2471
2023
Q3 		$867 Sell
50
-1,083
-96% -$18.8K ﹤0.01% 2416
2023
Q2 		$20.5K Buy
+1,133
New +$26.8K ﹤0.01% 2094
2022
Q2 		– Sell
-8,000
Closed -$56K – 2478
2022
Q1 		$56K Buy
+8,000
New +$81.6K ﹤0.01% 1803
2021
Q3 		– Sell
-1,400
Closed -$41 – 2322
2021
Q2 		$41 Buy
+1,400
New +$43.6K ﹤0.01% 1988

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Nisa Investment Advisors's PLRX Position: Q3 2025 in Review

Nisa Investment Advisors sold out of Pliant Therapeutics (PLRX) in Q3 2025, closing a stake of 916 shares — an estimated $1.06K sold.

Nisa Investment Advisors first reported a position in PLRX in Q2 2021 and held it in 11 quarters. The position peaked at $56K in Q1 2022. 99 funds tracked by Wall St. Rank hold PLRX as of Q3 2025.

  • Nisa Investment Advisors reported no remaining Pliant Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Nisa Investment Advisors sold 916 Pliant Therapeutics shares in Q3 2025, an estimated $1.06K.
  • Nisa Investment Advisors first reported a position in Pliant Therapeutics in Q2 2021 and held it in 11 quarters.
  • Nisa Investment Advisors's Pliant Therapeutics position peaked at $56K in Q1 2022.
  • 99 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q3 2025.

Based on Nisa Investment Advisors's 13F filing for Q3 2025, filed 23 Oct 2025.